New Expert Guidance for Use of Anti-Amyloids for Early AD New Expert Guidance for Use of Anti-Amyloids for Early AD

Patient selection and discussions surrounding side effects and expectations are key when considering prescribing lecanemab and potentially other therapies targeting brain amyloid.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Psychiatry News Source Type: news